Published in
Taylor and Francis Group, Scandinavian Journal of Rheumatology, 3(51), p. 237-240, 2021
DOI: 10.1080/03009742.2021.1980979
Links
Tools
Refractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy
Journal article published in 2021 by
R. Biesen 
,
M. Frese-Schaper,
P. Enghard,
Q. Cheng,
F. Hiepe,
S. Frese
,
M. Frese-Schaper,
P. Enghard,
Q. Cheng,
F. Hiepe,
S. Frese
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 